Annual Report to the Community

New Funding Fuels Development of First Potentially Regenerative Treatment for Multiple Sclerosis

A Canadian-led international research team, spearheaded by Dr. Fang Liu at CAMH has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance a promising therapy for multiple sclerosis (MS).